Analytical Data
-
Gene name
TMEM65
- Application
-
Alternative Names
TMEM65; TMM65_HUMAN; Transmembrane protein 65
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6PI78
-
Expression Region
63-240aa
-
Molecular Weight
35.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TMEM65 is a relatively newly identified protein that belongs to the family of transmembrane proteins and has gained attention due to its potential role in cellular processes and disease mechanisms. Recent studies have suggested that mutations in the TMEM65 gene are linked to various metabolic disorders, particularly in mitochondrial dysfunction. The protein is thought to be involved in crucial cellular pathways, including those related to energy metabolism and apoptosis. As a result, the research surrounding recombinant TMEM65 protein has become increasingly relevant, as it may provide insights into the molecular functions of TMEM65 and its role in health and disease. By producing recombinant TMEM65, researchers aim to elucidate its structural characteristics, interaction networks, and functional roles in cell biology. Understanding these aspects may facilitate the development of targeted therapeutic strategies for diseases associated with TMEM65 mutations. Given the rise of interest in personalized medicine and metabolic disorders, investigating TMEM65 could also offer broader implications for understanding the biology of transmembrane proteins in general.
